INV: Innventure Group P/E multiplikatori

Innventure Group - INV emitenti grafik logotipi

Innventure, Inc. (INV) global korporatsiyalarning ilg'or ishlanmalari asosida avtonom va daromadli korxonalarni tashkil etish orqali ularni monetizatsiya qiladi. Biznesni kengaytirish xomashyoni qayta ishlash va ekologik qadoqlash loyihalarini ishga tushirish orqali amalga oshirilmoqda. Aksiyalar joriy narxining ushbu grafigi -0.10 qiymatini ko'rsatmoqda, kompaniyaning daromadliligi esa mijozlarning ishlab chiqarish xarajatlarini optimallashtirishdan foyda ko'rish imkonini beruvchi eksklyuziv patent huquqlariga tayanadi.

INV: Innventure Narxning foydaga nisbati 04.10.2024 - 12.11.2026

Innventure Corp (INV) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning har tomonlama tahlili:innventure.com - INV
Innventure Corp original mahsuloti

P/E koeffitsiyenti bozor narxining sof foydaga nisbatini ko'rsatish orqali investitsiyalarning qoplanish muddatini aks ettiradi. Kompaniya moliyaviy hisobotlari asosida P/E tahlilini o'tkazish balans hisobining tashqi zarbalarga sezgirligini aniqlash va aktivlar qiymatini qarz xizmati xarajatlari bilan solishtirish imkonini beradi. Ko'rsatkichlar tebranishlar diapazonining torayishi baholashning barqarorlashganini yoki yashirin pul oqimi bo'shliqlari mavjudligini bildiradi. Innventure, Inc. (INV) uchun bunday shaffoflik operatsion xarajatlarni minimallashtiruvchi yuridik yordamni autsorsing qilish orqali ta'minlanadi.

Muhim raqobatchilar

Kapitalizatsiyaning foydaga nisbati cintas.com CTAS|Narx-foyda koeffitsiyenti TRI (Thomson Reuters Corporation)|P/E multiplikatori Houlihan Lokey Inc (HLI)|Booz Allen Hamilton Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati RTO (Rentokil Initial Group)|EXLS - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati pjtpartners.com PJT|Moelis (MC) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati FTI Consulting Inc (FCN)|Narx-foyda koeffitsiyenti CNXC|P/E multiplikatori Exponent Corp|Narxning foydaga nisbati WNS (Holdings) Limited (WNS)|CBZ (cbiz.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ABM (ABM Industries Incorporated)|TIC - Narx-foyda koeffitsiyenti|LegalZoom Inc - P/E multiplikatori|Biznesning o‘zini qoplash muddati ICF Corp ICFI|TaskUs, Inc. (TASK) - Narxning foydaga nisbati|Narx-foyda multiplikatori WLDN|CRAI (CRA International) - P/E multiplikatori|TIXT - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori DLX|Biznesning o‘zini qoplash muddati Performant Healthcare Corp|Narxning foydaga nisbati The Hackett Group, Inc. HCKT|IBEX: Narx-foyda multiplikatori|ANPA - Narxning foydaga nisbati|XRX (Xerox Holdings Corporation) - Narx-foyda multiplikatori|CNDT (Conduent Inc) - Narx-foyda koeffitsiyenti|KFS (Kingsway Financial) - Narxning foydaga nisbati|LPRO (Open Lending) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati RCM Tech RCMT|Narxning foydaga nisbati TTEC Holdings, Inc. (TTEC)|rgp.com - Narx-foyda multiplikatori|Enigmatig - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati TISI (Team Industrial Services)|PMEC: Narx-foyda koeffitsiyenti|ACCS - P/E multiplikatori|Harte Hanks (HHS) - Narxning foydaga nisbati|rYojbaba - Kompaniya qiymatining sof foydaga nisbati|SPPL (Simpple Ltd) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Greenpro GRNQ|Narx-foyda koeffitsiyenti WAI (Top KingWin Ltd)|QH (quhuo.cn) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori PMAX (Powell Max)|Biznesning o‘zini qoplash muddati Lichen China Ltd (LICN)|BMHL - Narxning foydaga nisbati|ZGM (Zenta Group Co. Ltd) - Narx-foyda multiplikatori|FOFO: P/E multiplikatori|Narx-foyda koeffitsiyenti ARC Document Solutions, Inc.|Narx-foyda koeffitsiyenti GVP|NV5 Global (NVEE) - Biznesning o‘zini qoplash muddati|P/E multiplikatori PFMT|Biznesning o‘zini qoplash muddati sterlingcheck.com|Narxning foydaga nisbati TDCX Inc TDCX